Publication | Closed Access

Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas

Tumor BiologyHuman CarcinomasOncogenic AgentMedicineReceptor Tyrosine KinasePathologyCancer BiologyTumor SuppressorOncologyCell BiologyTumor MicroenvironmentCancer Research